Literature DB >> 9667485

Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis: implications for periodontal diagnosis.

I B Lamster1, I Kaluszhner-Shapira, M Herrera-Abreu, R Sinha, J T Grbic.   

Abstract

The relationship of the serum antibody titer and avidity to the putative periodontal pathogens Actinobacillus actinomycetemcomitans (Aa) strains Y4 and 29523 and Porphyromonas gingivalis (Pg) strain 381 were examined in relation to clinical parameters in 26 gingivitis and 28 periodontitis patients. The relationship of antibody titer and avidity to infection with the homologous organism was also examined in a subset of 30 patients. Antibody titer was determined by an enzyme-linked immunosorbent assay, and antibody avidity was assessed using a dissociation assay. Considering all patients, there was a significant negative correlation between mean probing depth and antibody titer (r=-0.28) and avidity (r=-0.28) to Aa Y4. There was a significant positive correlation of probing depth and antibody titer (r=0.46) and avidity (r=0.46) to Pg. The correlation of antibody titer and avidity to Aa and infection with Aa Y4 (r=-0.32, r=-0.21) and Aa 29523 (r=-0.35, r=-0.39) was negative, while the correlations of titer and avidity to Pg and presence of the organisms was strongly positive (r=0.40, r=0.35). These data indicate that the relationship of serum antibody titer and avidity to clinical parameters of periodontal disease severity and the level of infection with the homologous organism appears to be different for Aa and Pg. The development of an antibody response to Aa appears to protect the individual from infection with the organism. In contrast, the development of an antibody response to Pg was not able to eliminate the infection. These results should be considered when developing a diagnostic strategy for periodontal disease utilizing the humoral immune response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667485     DOI: 10.1111/j.1600-051x.1998.tb02480.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  11 in total

1.  Antigenically diverse reference strains and autologous strains of Actinobacillus actinomycetemcomitans are equally efficient antigens in enzyme-linked immunosorbent assay analysis.

Authors:  Tiina Vilkuna-Rautiainen; Pirkko J Pussinen; Kimmo Mattila; Marja Vesanen; Heidi Ahman; Başak Doğan; Sirkka Asikainen
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Prognosis of periodontitis recurrence after intensive periodontal treatment using examination of serum IgG antibody titer against periodontal bacteria.

Authors:  Noriko Sugi; Koji Naruishi; Chieko Kudo; Aya Hisaeda-Kako; Takayuki Kono; Hiroshi Maeda; Shogo Takashiba
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

3.  Treatment resistance of rheumatoid arthritis relates to infection of periodontal pathogenic bacteria: a case-control cross-sectional study.

Authors:  Kazu Takeuchi-Hatanaka; Yoshinobu Koyama; Kentaro Okamoto; Kyosuke Sakaida; Tadashi Yamamoto; Shogo Takashiba
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

4.  Association between groups of immunoglobulin G antibodies against periodontal microorganisms and diabetes-related mortality.

Authors:  Anwar T Merchant; Nadeesha Vidanapathirana; Fanli Yi; Owen Celuch; Zihang Zhong; Qi Jin; Jiajia Zhang
Journal:  J Periodontol       Date:  2022-04-06       Impact factor: 4.494

5.  Vaccination with recombinant RgpA peptide protects against Porphyromonas gingivalis-induced bone loss.

Authors:  A Wilensky; J Potempa; Y Houri-Haddad; L Shapira
Journal:  J Periodontal Res       Date:  2016-06-10       Impact factor: 4.419

6.  Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease.

Authors:  Mikihito Kajiya; Gabriela Giro; Martin A Taubman; Xiaozhe Han; Marcia P A Mayer; Toshihisa Kawai
Journal:  J Oral Microbiol       Date:  2010-11-08       Impact factor: 5.474

7.  Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis.

Authors:  Sheila L Arvikar; Deborah S Collier; Mark C Fisher; Sebastian Unizony; George L Cohen; Gail McHugh; Toshihisa Kawai; Klemen Strle; Allen C Steere
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

8.  Periodontal pathogens and the association between periodontitis and rheumatoid arthritis in Korean adults.

Authors:  Jin-Hee Kim; In Ah Choi; Joo Youn Lee; Kyoung-Hwa Kim; Sungtae Kim; Ki-Tae Koo; Tae-Il Kim; Yang-Jo Seol; Young Ku; In-Chul Rhyu; Yeong Wook Song; Yong-Moo Lee
Journal:  J Periodontal Implant Sci       Date:  2018-12-28       Impact factor: 2.614

9.  Relationship between periodontitis-related antibody and frequent exacerbations in chronic obstructive pulmonary disease.

Authors:  Tamaki Takahashi; Shigeo Muro; Naoya Tanabe; Kunihiko Terada; Hirofumi Kiyokawa; Susumu Sato; Yuma Hoshino; Emiko Ogawa; Kazuko Uno; Koji Naruishi; Shogo Takashiba; Michiaki Mishima
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

10.  Association between anti-Porphyromonas gingivalis or anti-α-enolase antibody and severity of periodontitis or rheumatoid arthritis (RA) disease activity in RA.

Authors:  Joo Youn Lee; In Ah Choi; Jin-Hee Kim; Kyoung-Hwa Kim; Eun Young Lee; Eun Bong Lee; Yong-Moo Lee; Yeong Wook Song
Journal:  BMC Musculoskelet Disord       Date:  2015-08-12       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.